Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients
2008

Detecting Bacteria in Sputum from Cystic Fibrosis Patients

Sample size: 25 publication 10 minutes Evidence: high

Author Information

Author(s): Bittar Fadi, Richet Hervé, Dubus Jean-Christophe, Reynaud-Gaubert Martine, Stremler Nathalie, Sarles Jacques, Raoult Didier, Rolain Jean-Marc

Primary Institution: Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), CNRS-IRD, UMR 6236, Faculté de Médecine et de Pharmacie, Université de la Méditerranée, Marseille, France

Hypothesis

Can molecular methods improve the identification of bacteria in sputum samples from cystic fibrosis patients compared to traditional culture methods?

Conclusion

The study found a complex microbial community in the sputum of cystic fibrosis patients, highlighting the presence of many anaerobic bacteria that are often overlooked.

Supporting Evidence

  • Twenty-five sputum samples were collected from cystic fibrosis patients.
  • 53 different bacterial species were identified, including 16 species of anaerobes.
  • 57.6% of isolated bacteria were found only after cloning and sequencing.

Takeaway

Doctors looked at the germs in the spit of kids and adults with cystic fibrosis and found a lot more types of germs than they usually see, especially some that are hard to find.

Methodology

The study compared traditional culture methods with molecular techniques like 16S rDNA amplification and sequencing to identify bacteria in sputum samples.

Limitations

The study did not analyze the role of fungi and viruses in the sputum samples.

Participant Demographics

16 children (average age 8.9 years) and 9 adults (average age 29 years) with cystic fibrosis.

Statistical Information

P-Value

0.05

Statistical Significance

p=0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0002908

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication